Tianjin Cansino Biotechnology Inc   Report issue

Founded: Tianjin China (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2014
NCT02326194
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CanSino Biologics Inc.